Clinical Research in Cardiology Supplements最新文献

{"title":"[Three-dimensional reconstruction and remote navigation for catheter-guided atrial fibrillation ablation. Does it influence procedural outcomes?].","authors":"Daniel Steven,&nbsp;Boris Hoffmann,&nbsp;Thomas Rostock,&nbsp;Imke Drewitz,&nbsp;Arian Sultan,&nbsp;Helge Servatius,&nbsp;Jakob Lüker,&nbsp;Kai Müllerleile,&nbsp;Stephan Willems","doi":"10.1007/s11789-011-0028-0","DOIUrl":"https://doi.org/10.1007/s11789-011-0028-0","url":null,"abstract":"<p><p>Catheter ablation of atrial fibrillation has evolved as a widely accepted therapy approach and is now also incorporated in the current guidelines.A major limitation consists of the limited three-dimensional visualization of the complex three-dimensional structures in the left atrium since most procedures have routinely been performed using fluoroscopy alone. Another unsolved problem is the limited durability of lesions sets performed with radiofrequency ablation and therefore somewhat disappointing long-term ablation results besides fluoroscopy exposition for patient and operator as required for safe catheter manipulation.In the recent years we have gained substantial insight with respect to arrhythmia mechanism. At the same time new techniques and developments have become available to improve catheter ablation results.The present article summarizes the available opportunities with respect to three-dimensional mapping including CT/MRI image integration and gives an overview of the robotic and magnetic systems available for catheter ablation.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"73-7"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0028-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40177831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Non-invasive diagnostics of chronic stable coronary artery disease: evidence-based and non-evidence-based diagnostic algorithms].","authors":"Rolf Dörr,&nbsp;Reinhardt Sternitzky","doi":"10.1007/s11789-011-0027-1","DOIUrl":"https://doi.org/10.1007/s11789-011-0027-1","url":null,"abstract":"<p><p>In Germany, every second left heart catheterization has no immediate interventional or surgical consequence. One main reason for this limited quality of indication of many left heart catheterizations is presumably the inaccuracy of preinvasive testing that is mainly based on clinical evaluation and exercise ECG in Germany. However, exercise electrocardiography has several limitations. The central issues are the inability to exercise in many, especially elderly patients, and the missing interpretability of the stress ECG in cases with already pathological rest ECG. In 2006, the \"Nationale Versorgungsleitlinie Chronische KHK (NVL KHK)\" was published in Germany, adopting for the first time the evidence-based algorithms of the American College of Cardiology/American Heart Association (ACC/AHA) guidelines for non-invasive stress testing and complementary stress imaging. Stress imaging methods considered comparable and interchangeable are the following: stress echocardiography combined with physical or pharmacological stress testing, myocardial perfusion imaging with physical or pharmacological stress testing, dobutamine stress magnetic resonance imaging (DSMR), or myocardial perfusion magnetic resonance imaging (MRI). Basically, no stress imaging method is definitely superior to the others, each method has its own advantages and disadvantages that should be considered and adjusted to the individual patient. Of pivotal importance of all stress imaging methods is the high negative predictive value of 99% of a normal study predicting a very low (< 1%) cumulative likelihood of cardiac death or myocardial infarction for at least the next 12 months. Hence, in most clinical circumstances, coronary angiography is not necessary during the 12 months subsequent to a normal stress imaging study. In contrast to these established and evidence-based recommendations of the \"Nationale Versorgungsleitlinie Chronische KHK\" mainly focusing on ischemia stress imaging, many diagnostic centers have developed their own non-evidence based algorithms. In these non-evidence based algorithms the morphology-oriented non-invasive CT coronary angiography has taken over the diagnostic part of evidence-based ischemia stress imaging. However, beyond the scientifically established prognostic value of calcium scoring, there is so far no scientific evidence showing that morphology-oriented CT coronary angiography protocols are superior to functional stress imaging. A new innovative approach of staged non-invasive diagnostics for patients with intermediate likelihood (10-90%) of coronary artery disease are the 2010 recommendations of the National Institute for Health and Clinical Excellence (NICE) guiding the National Health Service (NHS) in the United Kingdom. Following this guidance, in patients with an estimated likelihood of CAD of 10-29% CT calcium scoring should be offered as first-line method, in patients with an estimated likelihood of CAD of 30-60% non-invasive functional i","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"17-24"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0027-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[3-year results of the SYNTAX trial--stent or surgery? A surgeon's perspective].","authors":"Lenard Conradi,&nbsp;Hermann Reichenspurner","doi":"10.1007/s11789-011-0023-5","DOIUrl":"https://doi.org/10.1007/s11789-011-0023-5","url":null,"abstract":"<p><p>Coronary artery bypass grafting (CABG) is the standard of care for patients with three-vessel or left main coronary artery disease. However, clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by percutaneous coronary intervention (PCI) today. An abundancy of both large registries and randomized clinical trials has demonstrated superiority of surgery over PCI in advanced coronary artery disease. Recently, these results have been confirmed by the landmark SYNTAX trial where CABG was found to be superior to PCI for three-vessel and/or left main coronary artery disease regarding repeat revascularization, rate of myocardial infarction, and cardiac mortality at the latest follow-up of 3 years. On the other hand, PCI proved to be a viable alternative for less complex forms of left main disease.In conclusion, patients with three-vessel and/or left main coronary artery disease should be discussed in an interdisciplinary heart team consisting of cardiologists and cardiac surgeons within a heart center. Final decision making should be a formal process as recommended in the recently updated guidelines on myocardial revascularization by the European Society of Cardiology.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"43-8"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0023-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40177827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Anticoagulation in atrial fibrillation. Strategies in special situations].","authors":"Hans Volkmann,&nbsp;M Walter,&nbsp;C Walter,&nbsp;S Vetter","doi":"10.1007/s11789-011-0022-6","DOIUrl":"https://doi.org/10.1007/s11789-011-0022-6","url":null,"abstract":"<p><p>Morbidity and mortality associated with atrial fibrillation are mainly related to thromboembolic complications, particularly ischemic strokes. The prevention of thromboembolism is an important component of the management of patients with atrial fibrillation. The choice of optimum antithrombotic therapy for a given patient depends on the risk of thromboembolism, on the one hand, and the risk of intracerebral hemorrhage, on the other hand. Concerning the benefit-to-risk stratification, the problem lies in the similar and sometimes even identical risk factors for both thromboembolism and hemorrhage.At present, oral vitamin K antagonists are recommended for patients with atrial fibrillation at moderate or high risk of ischemic stroke. The thromboembolic risk should be assessed using validated stratification schemes, such as the CHADS(2) score for basic orientation and the CHA(2)DS(2)VASc score for extended risk stratification. Aspirin alone is recommended for patients at low risk of thromboembolic complications. Problems in antithrombotic therapy of atrial fibrillation arise treating those patients undergoing percutaneous coronary intervention and stent implantation, those with contraindication for vitamin K antagonists, or those with persisting left atrial thrombus requiring electrical cardioversion. The optimum therapeutic management of these special patients has not yet been defined by proper studies, leaving only empirically based recommendations for their treatment.Hopefully the development of new antithrombotic agents, that are easier to use and have a superior benefit-to-risk ratio, will extend effective prevention of thromboembolic events to a greater part of the atrial fibrillation population at risk.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"58-65"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0022-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40177829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Transapical aortic valve implantation--indications, risks and limitations].","authors":"U Kappert,&nbsp;Dominik Joskowiak,&nbsp;S M Tugtekin,&nbsp;K Matschke","doi":"10.1007/s11789-011-0025-3","DOIUrl":"https://doi.org/10.1007/s11789-011-0025-3","url":null,"abstract":"<p><p>Calcified aortic stenosis is the predominant valve disease in the western world. Currently, surgical aortic valve replacement is the gold standard procedure for symptomatic severe aortic stenosis that can be performed with low morbidity and mortality. The prevalence of aortic stenosis increases with age, and the incidence of several comorbidities also unavoidably elevates the risk of surgical treatment. Therefore, the most adequate and gentle treatment is needed especially for this population. Since the first transcatheter aortic valve implantation (TAVI) was performed in 2002, the main implanting routes are the transfemoral, retrograde access through the common femoral artery, and the antegrade, transapical approach via anterolateral minithoracotomy. Meanwhile, TAVI has become an alternative treatment for patients who are not suitable candidates for surgical therapy in some centers.The initial clinical results are promising and have confirmed the feasibility of this technique. Due to the restricted long-term data, conventional aortic valve replacement still remains the standard for the treatment of aortic stenosis. Selection of the suitable therapy approach (surgical replacement, transfemoral or transapical aortic valve implantation) must consider each patient's specific risk profile and individual indication. Prospective, randomized trials will be necessary to assess the individual survival benefit of TAVI for various risk populations and to extend the indication.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"49-57"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0025-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40177828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[On the history of heart failure].","authors":"B Lüderitz","doi":"10.1007/s11789-011-0026-2","DOIUrl":"https://doi.org/10.1007/s11789-011-0026-2","url":null,"abstract":"<p><p>The heart is by far the organ that is best known and has been identified for a long time. Myogenic weakness of the heart muscle pump with left-ventricular dysfunction remains the cardiac disease with the poorest prognosis while increasing in prevalence and incidence. Aside from all sorts of mystic treatment attempts and dubious herbal medicine, bloodletting was established early on as a superior remedy, which was applied in response to almost all cardiac illnesses. The first and perhaps most important cardiac drug was digitalis, the glycoside of the red and even more so of the white foxglove, described in 1552 by Leonhart Fuchs. In the 1980s, vasodilators and inotropic drugs supplemented the classical medications digitalis and diuretics. ACE inhibitors and beta-receptor blockers were added in the 1990s; at the turn of the millennium, the cardiac resynchronization therapy (CRT) and left-heart assist systems were developed; lately, there have been cellular and genetic approaches as well as xenotransplants. Preliminary results with stem cell technology are encouraging; however, it will be years until a clinical application-if it will happen at all.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"2-5"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0026-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Diabetes, sport and exercise].","authors":"Hermann Fischer","doi":"10.1007/s11789-011-0029-z","DOIUrl":"https://doi.org/10.1007/s11789-011-0029-z","url":null,"abstract":"<p><p>Physical activity is an essential element in the therapy of type 2 Diabetes mellitus. For physicians and therapists, it is of vital importance to motivate each patient to include exercise into routine daily life. Individual therapy plans are, thus, required.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"6-9"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0029-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Multimodal therapy of dyslipidemia].","authors":"Annett Stahn,&nbsp;Markolf Hanefeld","doi":"10.1007/s11789-011-0031-5","DOIUrl":"https://doi.org/10.1007/s11789-011-0031-5","url":null,"abstract":"<p><p>In the multifactorial process of atherogenesis not only increased LDL-cholesterol but also decreased HDL-cholesterol and raised triglycerides correlate closely to cardiovascular events. Multiple studies have demonstrated a high prevalence of dyslipidemia and the metabolic syndrome in Germany.Statins remain first-line therapy for the treatment of dyslipidemia. However, despite therapy a relevant cardiovascular risk remains. Therefore, it is important to also aim for an adequate treatment of hypertriglyceridemia and also to raise HDL-levels. Many combination therapies have been shown to be effective in treating dyslipidemia. Adding Omega-3-fatty acids, nicotinic acid/laropiprant or a fibrate to statin monotherapy provide additional beneficial lipid-modifying effects for combined dyslipidemia. In the future a recommendation for the treatment of mixed hyperlipoproteinemia with decreased HDL, raised triglycerides and LDL-cholesterol shall have to be added to our guidelines.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"10-6"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0031-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Cardiac hybrid imaging].","authors":"Oliver Gaemperli,&nbsp;Philipp A Kaufmann","doi":"10.1007/s11789-011-0024-4","DOIUrl":"https://doi.org/10.1007/s11789-011-0024-4","url":null,"abstract":"<p><p>CT coronary angiography and myocardial perfusion scintigraphy are both established noninvasive techniques for the diagnosis of coronary artery disease (CAD). Cardiac hybrid imaging consists of the combination (or fusion) of both modalities and allows obtaining complementary morphological (coronary anatomy, stenoses) and functional (myocardial perfusion) information in a single image. The increased availability of these techniques in clinical practice has also raised a controversy with regard to which patients should undergo such integrated examinations. The feasibility and clinical value of hybrid imaging has been documented in small cohort studies and selected series of patients. The incremental value of the hybrid technique arises from the spatial co-registration of perfusion defects with coronary stenoses. This allows an assessment of the hemodynamic relevance of coronary stenoses and the determination of the need for revascularization procedures in each individual artery. Thus, it can be anticipated that the ongoing efforts to reduce radiation exposure and the increasing clinical interest will further pave the way for an ever-increasing use of cardiac hybrid imaging in clinical practice.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"32-42"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0024-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40178447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Catheter ablation of atrial fibrillation. Pulmonary vein isolation by using a new multipolar ablation catheter].","authors":"Stefan G Spitzer,&nbsp;Laszlo Karolyi","doi":"10.1007/s11789-011-0034-2","DOIUrl":"https://doi.org/10.1007/s11789-011-0034-2","url":null,"abstract":"<p><p>Catheter ablation of atrial fibrillation (AF) is an established therapeutical option, particularly in treatment of paroxysmal atrial fibrillation. This paper presents the results of using the PVAC multi-electrode ablation catheter (PVAC®, Medtronic Ablation Frontiers, Carlsbad, CA, USA). In 253 patients with paroxysmal or persistant AF, 1051 pulmonary veins were isolated, including ablation of 34 left common ostia and 1 right common ostium. Except one vein, all pulmonary veins in all patients were successfully isolated. In 23 patients with documented typical atrial flutter, the right atrial isthmus was additionally ablated within the same procedure. Follow-up (FU) visits were performed after 1, 3, 6 and 12 months with 12-lead-ECG, 24h-Holter-ECG and 4-days-Holter ECG. Mean FU was 11 ± 7 months with 1.1 interventions per patient (24 redo cases). During FU, 122 of 181 patients with paroxysmal AF (69%) and 23 of 40 patients with persistant AF (58%) were in stable sinus rhythm (SR) after ablation. 159 (62.8%) patients wer under antiarrhythmic drugs after ablation, 214 (84.5%) patients with additional β-blockers. Total procedure time was 71 ± 19 min, and total fluoroscopy time was 16 ± 6 min. In 3 cases (1.2%) procedure-related complications occured. Pulmonary vein isolation by using the PVAC-ablation catheter is a safe and effective method in treatment of paroxysmal and persistant AF.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"6 ","pages":"66-72"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-011-0034-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40177830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}